Company / Working Capital
CAPRICOR THERAPEUTICS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$287.1M
FY2025
5-year range
$19.3M / $287.1M
FY2021-FY2025
Trend
+101.7%
vs FY2024
Sector context
#146 of 213
Health Care
What the data says
At $287M, CAPRICOR THERAPEUTICS, INC.'s working capital ranks #146 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $19M in FY2022 to $287M in FY2025.
Based on SEC 10-K filings.
$287M in FY2025 with a 5-year CAGR of +56.4%.
Improved from $20M to $287M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +145.9%
- 5-Year CAGR
- +56.4%
- 10-Year CAGR
- -
Sector benchmark
#146 of 213 in Health CareTop 69% of 213This company $287.1M Sector average $934.6M
▼
-69.3% below sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of +56.4%, indicating consistent growth.
- In FY2025, working capital increased 101.7% year-over-year.
- Ranks #146 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.1M | +101.7% |
| FY2024 | $142.4M | +626.9% |
| FY2023 | $19.6M | +1.5% |
| FY2022 | $19.3M | -40.2% |
| FY2021 | $32.3M | +5.2% |
| FY2020 | $30.7M | +218.3% |
| FY2019 | $9.6M | +33.7% |
| FY2018 | $7.2M | -48.6% |
| FY2017 | $14.0M | +6.3% |
| FY2016 | $13.2M | +77.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026